Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) on Tuesday, began the production of Sputnik V COVID-19 vaccine in India. Russian Direct Investment Fund (RDIF) and Panacea Biotec will produce 100 million doses per year of Sputnik V in India. To know more, watch the full story!
